JP2002520368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002520368A5 JP2002520368A5 JP2000559870A JP2000559870A JP2002520368A5 JP 2002520368 A5 JP2002520368 A5 JP 2002520368A5 JP 2000559870 A JP2000559870 A JP 2000559870A JP 2000559870 A JP2000559870 A JP 2000559870A JP 2002520368 A5 JP2002520368 A5 JP 2002520368A5
- Authority
- JP
- Japan
- Prior art keywords
- pentanor
- cyclohexyl
- oxa
- chloro
- dihydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 Polypropylene Polymers 0.000 description 93
- 239000002253 acid Substances 0.000 description 60
- 239000004743 Polypropylene Substances 0.000 description 32
- 229920001155 polypropylene Polymers 0.000 description 32
- 150000003180 prostaglandins Chemical class 0.000 description 32
- 239000000203 mixture Substances 0.000 description 25
- 238000000034 method Methods 0.000 description 12
- 230000000699 topical effect Effects 0.000 description 11
- 150000002148 esters Chemical class 0.000 description 9
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 6
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 239000008389 polyethoxylated castor oil Substances 0.000 description 6
- MKPLKVHSHYCHOC-JPVYXPJZSA-N propan-2-yl (e)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(e,3r)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate Chemical compound CC(C)OC(=O)CCC\C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(C(F)(F)F)=C1 MKPLKVHSHYCHOC-JPVYXPJZSA-N 0.000 description 6
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 4
- FPABVZYYTCHNMK-YNRDDPJXSA-N PGF2alpha isopropyl ester Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OC(C)C FPABVZYYTCHNMK-YNRDDPJXSA-N 0.000 description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 3
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 3
- 239000008180 pharmaceutical surfactant Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- GGXICVAJURFBLW-RDSJPUOVSA-N propan-2-yl (e)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(3r)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate Chemical compound CC(C)OC(=O)CCC\C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-RDSJPUOVSA-N 0.000 description 3
- OCNSAYQJDKJOLH-AHTXBMBWSA-N propan-2-yl (z)-7-[(1r,2r,3r,5s)-2-[(e,3r)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(Cl)=C1 OCNSAYQJDKJOLH-AHTXBMBWSA-N 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 3
- 238000012856 packing Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9278698P | 1998-07-14 | 1998-07-14 | |
| US60/092,786 | 1998-07-14 | ||
| PCT/US1999/013276 WO2000003736A1 (en) | 1998-07-14 | 1999-06-15 | Prostaglandin product |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010017455A Division JP2010100652A (ja) | 1998-07-14 | 2010-01-28 | プロスタグランジン製品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002520368A JP2002520368A (ja) | 2002-07-09 |
| JP2002520368A5 true JP2002520368A5 (https=) | 2010-04-02 |
Family
ID=22235155
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000559870A Pending JP2002520368A (ja) | 1998-07-14 | 1999-06-15 | プロスタグランジン製品 |
| JP2010017455A Pending JP2010100652A (ja) | 1998-07-14 | 2010-01-28 | プロスタグランジン製品 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010017455A Pending JP2010100652A (ja) | 1998-07-14 | 2010-01-28 | プロスタグランジン製品 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1011728B1 (https=) |
| JP (2) | JP2002520368A (https=) |
| KR (1) | KR20010021835A (https=) |
| CN (1) | CN1146423C (https=) |
| AR (1) | AR019773A1 (https=) |
| AT (1) | ATE285795T1 (https=) |
| AU (1) | AU743607B2 (https=) |
| BR (1) | BR9906597A (https=) |
| CA (1) | CA2295512C (https=) |
| DE (1) | DE69922916T2 (https=) |
| ES (1) | ES2234270T3 (https=) |
| PT (1) | PT1011728E (https=) |
| TW (1) | TW585769B (https=) |
| WO (1) | WO2000003736A1 (https=) |
| ZA (1) | ZA997794B (https=) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000003736A1 (en) * | 1998-07-14 | 2000-01-27 | Alcon Laboratories, Inc. | Prostaglandin product |
| JP4834224B2 (ja) | 1999-03-05 | 2011-12-14 | デューク ユニバーシティ | C16不飽和fp−選択的プロスタグランジン類縁体 |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| JP4563636B2 (ja) * | 1999-09-10 | 2010-10-13 | 大正製薬株式会社 | プロスタグランジン誘導体 |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| CA2422031C (en) * | 2000-09-13 | 2011-11-15 | Santen Pharmaceutical Co., Ltd. | Ophthalmic solutions comprising difluoroprostaglandin f2 alpha |
| WO2002022106A2 (en) * | 2000-09-14 | 2002-03-21 | Novartis Ag | Stable ophthalmic preparation |
| EP1486192A4 (en) * | 2002-03-18 | 2010-07-14 | Santen Pharmaceutical Co Ltd | HIGH-TEMPERATURE-STERILIZABLE INSTILLER |
| DK1532981T3 (da) * | 2002-08-23 | 2008-01-28 | Santen Pharmaceutical Co Ltd | Stabile öjendråber, der indeholder latanoprost som den aktive bestanddel |
| WO2005011704A1 (ja) * | 2003-07-31 | 2005-02-10 | Santen Pharmaceutical Co., Ltd. | プロスタグランジン含有製品 |
| CN102526064A (zh) * | 2004-12-09 | 2012-07-04 | 参天制药株式会社 | 含有分子内具有氟原子的前列腺素的制品 |
| JP4753178B2 (ja) * | 2004-12-24 | 2011-08-24 | 参天製薬株式会社 | プロスタグランジンF2α誘導体含有製品 |
| WO2006068266A1 (ja) * | 2004-12-24 | 2006-06-29 | Santen Pharmaceutical Co., Ltd. | プロスタグランジンF2a誘導体含有製品 |
| JP5252787B2 (ja) * | 2005-08-02 | 2013-07-31 | 参天製薬株式会社 | 熱的に不安定な薬物の分解抑制方法 |
| EP1916002B1 (en) * | 2005-08-02 | 2014-03-05 | Santen Pharmaceutical Co., Ltd. | Method for prevention of degradation of thermally unstable substance |
| CN101400354B (zh) * | 2006-03-13 | 2014-10-22 | 株式会社·R-技术上野 | 水性组合物 |
| CN105566192B (zh) * | 2006-10-02 | 2019-01-22 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药 |
| US8455513B2 (en) | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
| WO2008096804A1 (ja) | 2007-02-07 | 2008-08-14 | Teika Pharmaceutical Co., Ltd. | ラタノプロスト含有点眼剤 |
| EP2193795B1 (en) * | 2007-08-29 | 2014-10-01 | Wakamoto Pharmaceutical Co., Ltd. | Latanoprost-containing aqueous pharmaceutical composition |
| WO2009084021A2 (en) * | 2007-10-16 | 2009-07-09 | Sun Pharma Advanced Research Company Limited | Novel ophthalmic compositions |
| TWI544927B (zh) * | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
| JP2009256281A (ja) * | 2008-04-21 | 2009-11-05 | Teika Seiyaku Kk | イソプロピルウノプロストン含有点眼剤組成物 |
| EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
| US8450344B2 (en) | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| US20100087540A1 (en) * | 2008-10-07 | 2010-04-08 | R-Tech Ueno, Ltd. | Pharmaceutical composition |
| CA2749352A1 (en) * | 2009-02-20 | 2010-09-10 | Micro Labs Limited | Storage stable prostaglandin product |
| EP3053913B1 (en) | 2009-05-01 | 2018-03-07 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
| DE102009021372A1 (de) * | 2009-05-14 | 2010-11-18 | Ursapharm Arzneimittel Gmbh | Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung |
| WO2011027778A1 (ja) * | 2009-09-01 | 2011-03-10 | 株式会社アールテック・ウエノ | 高眼圧症および緑内障処置のための眼局所投与用組成物 |
| EP2478906A4 (en) | 2009-09-17 | 2013-02-20 | Senju Pharma Co | AQUEOUS OPHTHALMIC DROPS THAT CONTAIN LATANOPROST, AND A METHOD OF INHIBITING ADSORPTION OF LATANOPROST ON A RESIN |
| US8658676B2 (en) | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
| EP2627173B2 (en) * | 2010-10-12 | 2018-07-04 | Chiesi Farmaceutici S.p.A. | Clevidipine emulsion formulations containing antimicrobial agents |
| EP2452669A1 (en) | 2010-10-29 | 2012-05-16 | Omnivision GmbH | Ophthalmic composition |
| EP2567689A1 (en) | 2011-09-12 | 2013-03-13 | Visiotact Pharma | Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid |
| DK3811943T3 (da) | 2013-03-15 | 2023-04-03 | Aerie Pharmaceuticals Inc | Forbindelse til anvendelse til behandling af øjenlidelser |
| ES2953346T3 (es) * | 2014-01-10 | 2023-11-10 | Santen Pharmaceutical Co Ltd | Composición farmacéutica que contiene un compuesto de ácido piridilaminoacético y aceite de ricino polioxietilenado |
| BR112016015909B1 (pt) | 2014-01-10 | 2020-09-29 | Santen Pharmaceutical Co., Ltd. | Composição farmacêutica contendo composto de ácido piridilaminoacético |
| JP5951921B1 (ja) * | 2014-12-12 | 2016-07-13 | 興和株式会社 | 組成物 |
| US9643927B1 (en) | 2015-11-17 | 2017-05-09 | Aerie Pharmaceuticals, Inc. | Process for the preparation of kinase inhibitors and intermediates thereof |
| KR102568079B1 (ko) * | 2016-08-31 | 2023-08-17 | 에어리 파마슈티컬즈, 인코포레이티드 | 안과용 조성물 |
| KR20190135027A (ko) | 2017-03-31 | 2019-12-05 | 에어리 파마슈티컬즈, 인코포레이티드 | 아릴 시클로프로필-아미노-이소퀴놀리닐 아미드 화합물 |
| AU2019337703B2 (en) | 2018-09-14 | 2023-02-02 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
| KR102756146B1 (ko) * | 2019-06-28 | 2025-01-17 | 한미약품 주식회사 | 저장 안정성이 개선된 라타노프로스트 함유 점안제 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3785602T2 (de) * | 1986-03-13 | 1993-09-02 | Univ Columbia | Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom. |
| JPS62292719A (ja) * | 1986-06-12 | 1987-12-19 | Kaken Pharmaceut Co Ltd | 外用澄明水溶性製剤 |
| ZA88963B (en) * | 1987-02-27 | 1989-11-29 | Allergan Inc | Prostaglandins useful for lowering intraocular pressure |
| JPH0228112A (ja) * | 1988-04-21 | 1990-01-30 | Kaken Pharmaceut Co Ltd | 点眼用眼圧調整剤 |
| JP3256997B2 (ja) * | 1990-08-30 | 2002-02-18 | 千寿製薬株式会社 | 安定な水性製剤 |
| US5425480A (en) * | 1992-12-17 | 1995-06-20 | Ryder International Corporation | Dose dispenser having a molded plastic housing with a cavity and a metallic foil wall covering the cavity |
| US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| JPH09124484A (ja) * | 1995-10-27 | 1997-05-13 | Schering Purau Kk | 点眼剤 |
| JPH10101863A (ja) * | 1996-09-30 | 1998-04-21 | Nippon Zeon Co Ltd | 成形材料 |
| WO2000003736A1 (en) * | 1998-07-14 | 2000-01-27 | Alcon Laboratories, Inc. | Prostaglandin product |
-
1999
- 1999-06-15 WO PCT/US1999/013276 patent/WO2000003736A1/en not_active Ceased
- 1999-06-15 CA CA002295512A patent/CA2295512C/en not_active Expired - Fee Related
- 1999-06-15 AT AT99931790T patent/ATE285795T1/de active
- 1999-06-15 AU AU48220/99A patent/AU743607B2/en not_active Ceased
- 1999-06-15 PT PT99931790T patent/PT1011728E/pt unknown
- 1999-06-15 EP EP99931790A patent/EP1011728B1/en not_active Revoked
- 1999-06-15 JP JP2000559870A patent/JP2002520368A/ja active Pending
- 1999-06-15 CN CNB998007757A patent/CN1146423C/zh not_active Ceased
- 1999-06-15 ES ES99931790T patent/ES2234270T3/es not_active Expired - Lifetime
- 1999-06-15 BR BR9906597-5A patent/BR9906597A/pt not_active Application Discontinuation
- 1999-06-15 DE DE69922916T patent/DE69922916T2/de not_active Expired - Lifetime
- 1999-06-15 KR KR1020007000399A patent/KR20010021835A/ko not_active Ceased
- 1999-06-22 TW TW088110467A patent/TW585769B/zh not_active IP Right Cessation
- 1999-07-13 AR ARP990103414A patent/AR019773A1/es unknown
- 1999-12-21 ZA ZA9907794A patent/ZA997794B/xx unknown
-
2010
- 2010-01-28 JP JP2010017455A patent/JP2010100652A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002520368A5 (https=) | ||
| CA2295512C (en) | Prostaglandin product | |
| US6235781B1 (en) | Prostaglandin product | |
| AU700574B2 (en) | Storage-stable prostaglandin compositions | |
| US6011062A (en) | Storage-stable prostaglandin compositions | |
| Bean et al. | Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences | |
| JPH08502485A (ja) | 緑内症(glaucoma)治療のための、プロスタグランジンとクロニジン誘導体の組合わせ | |
| JP2004532870A (ja) | 降圧脂質(プロスタグランジン誘導体)およびチモロールの組成物ならびにその使用方法 | |
| JP2013525508A (ja) | 新規な点眼組成物 | |
| JP2014515383A (ja) | PGF2α類似体を含む眼科用製剤 | |
| AU2001239551B2 (en) | Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof | |
| CN102215817B (zh) | 含前列腺素药物组合物 | |
| TW201247614A (en) | Aqueous ophthalmic composition | |
| US5627209A (en) | Use of certain 9-haloprostaglandins to treat glaucoma and ocular hypertension | |
| CN100496500C (zh) | 含布那唑嗪和前列腺素的青光眼治疗剂 | |
| TW200418490A (en) | Composition for treating ocular hypertension and glaucoma technical field | |
| JPH09124593A5 (https=) | ||
| HK1028563B (en) | Polypropylene containers for prostaglandin products | |
| JP2003528042A5 (https=) | ||
| HK1159501B (en) | Pharmaceutical composition comprising a prostaglandin | |
| AU2007200821A1 (en) | Hypotensive lipid and timolol compositions and methods of using same | |
| HK1070830B (en) | Hypotensive lipid and timolol compositions and methods of using same | |
| MXPA00002550A (es) | Producto de prostaglandina |